Vimarsana
Biggest News Aggregation in the World

Page 40 - Inducement Plan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Inducement Plan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Inducement Plan Today - Breaking & Trending Today

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02.12.2021 - RESEARCH TRIANGLE PARK, N.C., Dec. 01, 2021 (GLOBE NEWSWIRE) - G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the grant of inducement stock options exercisable for an aggregate of 101,700 shares of G1’s ...

NeuroBo Pharmaceuticals Appoin - GuruFocus.com - Vimarsana News

NeuroBo Pharmaceuticals Appoin - GuruFocus.com

GuruFocus Article or News written by PRNewswire and the topic is about:

Evolve Reports New Employment Inducement Awards Under NYSE American Listing Rules - Vimarsana News

Evolve Reports New Employment Inducement Awards Under NYSE American Listing Rules

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
NeuroBo Pharmaceuticals Appoints Gil Price, M.D. as President and Chief Executive Officer - Vimarsana News

NeuroBo Pharmaceuticals Appoints Gil Price, M.D. as President and Chief Executive Officer

/PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal...

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Vimarsana News

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported the grant of stock options to purchase an aggregate of 469,000 shares of common stock...